Therapeutic effects of a fusogenic newcastle disease virus in treating head and neck cancer
about
Oncolytic therapy of a recombinant Newcastle disease virus D90 strain for lung cancer.Oncolytic viruses: From bench to bedside with a focus on safety.Oncolytic vaccinia virus therapy of salivary gland carcinomaOncolysis by paramyxoviruses: preclinical and clinical studies.Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency.Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer.Effective oncolytic vaccinia therapy for human sarcomas.Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions.Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm.Evaluation of the oncolytic potential of R2B Mukteshwar vaccine strain of Newcastle disease virus (NDV) in a colon cancer cell line (SW-620).Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma.Antineoplastic activity of Newcastle disease virus strain D90 in oral squamous cell carcinoma.Oncolytic virotherapy for head and neck cancer: current research and future developments.Theranostic potential of oncolytic vaccinia virus.An oncofetal antigen, IMP-3-derived long peptides induce immune responses of both helper T cells and CTLs.PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy.Oncolytic effect of wild-type Newcastle disease virus isolates in cancer cell lines in vitro and in vivo on xenograft model.
P2860
Q33655291-3CA11C74-7EAB-48C3-BFB2-93383980BD66Q34044071-4FCD8A58-027A-48C7-B987-954A4043AEB5Q35549696-C63EF264-9C8D-4F2F-85EE-9915FCC6064DQ35861933-6050950C-0300-4185-B911-FDAF750DB2A5Q35861936-59C92BBD-9C93-494A-9372-9D3144629E91Q35916537-EAEA3DB5-63C2-4509-9123-67D51F43DF8FQ35954052-F9F4850F-1807-4877-A2CD-7CEEF51D784FQ37990940-B0457859-A6F3-447C-A5CA-548A49A7D0CBQ38264652-F3ECA796-1EEF-43F9-A4AC-97ADA5F3A2D3Q38701351-67B0F5E3-D70B-41A4-88B1-BB96BA9FF6B8Q38860227-02586075-D5F3-48FF-B756-F1EFA41CC194Q38886736-F6B8E20D-4003-4D5C-8BBF-96C71E4CDB8BQ38924562-F915762F-B180-4BA3-A9E4-7121ACDAF914Q39628429-F69F4ECB-FCA5-4D2E-93A7-4C3970723545Q42427592-B521639B-5527-468D-BD51-8B8664D03BCAQ52674215-73D46D67-3FAA-4C80-A7FE-A5F7A335F03DQ54241184-E80D0628-1A0B-4A1C-B3BF-18A97D66820F
P2860
Therapeutic effects of a fusogenic newcastle disease virus in treating head and neck cancer
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Therapeutic effects of a fusog ...... treating head and neck cancer
@ast
Therapeutic effects of a fusog ...... treating head and neck cancer
@en
type
label
Therapeutic effects of a fusog ...... treating head and neck cancer
@ast
Therapeutic effects of a fusog ...... treating head and neck cancer
@en
prefLabel
Therapeutic effects of a fusog ...... treating head and neck cancer
@ast
Therapeutic effects of a fusog ...... treating head and neck cancer
@en
P2093
P2860
P356
P1433
P1476
Therapeutic effects of a fusog ...... treating head and neck cancer
@en
P2093
Chun-Hao Chen
Dmitriy Zamarin
Pingdong Li
Richard J Wong
Yuman Fong
Zhenkun Yu
P2860
P304
P356
10.1002/HED.21609
P577
2010-11-04T00:00:00Z